Literature DB >> 10647060

The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.

K Kobayashi1, T M Forte, S Taniguchi, B Y Ishida, K Oka, L Chan.   

Abstract

Diabetic dyslipidemia is a major factor contributing to the accelerated atherosclerosis in type 2 diabetes mellitus. Although several mouse models are available, the plasma lipoproteins in response to diet have not been fully characterized in these animals. In this study, we have characterized the plasma lipoproteins and related apolipoproteins, as well as the vascular lipases, in diabetes (db/db) mice and their nondiabetic controls (+/?) in the C57BL/KsJ strain. Within 6 weeks of age, db/db mice developed significant obesity, fasting hyperglycemia, and hyperinsulinemia. By FPLC analysis, db/db mice showed a prominent peak in the low-density lipoprotein (LDL) range that was absent in +/? mice, although high-density lipoprotein (HDL) was the predominant species in both groups of animals. Postheparin lipoprotein lipase (LPL) activity in db/db mice was 28% of the level in +/? mice. Upon feeding a human-like 0.15% (wt/wt) cholesterol and 21% (wt/wt) fat "Western" diet, db/db mice developed elevated plasma cholesterol, accompanied by an exaggerated apolipoprotein E (apoE) response compared with +/? mice. FPLC analysis showed that the marked hypercholesterolemic response in db/db mice was the result of a massive increase in the LDL region, which overshadowed a moderate increase in HDL. We next isolated lipoproteins by ultracentrifugation and characterized them by nondenaturing gradient gel electrophoresis. With regular chow, db/db mice had almost exclusively small dense LDL with a peak size at 21.4 nm, as compared with 26.6 nm in nondiabetic controls. On the Western diet, the small dense LDLs persisted but larger particles also appeared in db/db mice, whereas the size distribution in +/? mice was unchanged by the diet. Our results suggest that db/db mice fed a Western diet have a plasma lipoprotein phenotype that shows some similarities to that in patients with type 2 diabetes mellitus, and that db/db mice are a useful model to study the pathogenesis and treatment of diabetic dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10647060     DOI: 10.1016/s0026-0495(00)90588-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  86 in total

1.  Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633.

Authors:  Ming Chen; Bing Yi; Ni Zhu; Xin Wei; Guan-Xin Zhang; Shengdong Huang; Jianxin Sun
Journal:  Cardiovasc Res       Date:  2015-11-23       Impact factor: 10.787

2.  Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance.

Authors:  David Jelinek; Veronica Millward; Amandip Birdi; Theodore P Trouard; Randall A Heidenreich; William S Garver
Journal:  Hum Mol Genet       Date:  2010-10-29       Impact factor: 6.150

3.  Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes.

Authors:  M Friederich Persson; S Franzén; S-B Catrina; G Dallner; P Hansell; K Brismar; F Palm
Journal:  Diabetologia       Date:  2012-02-05       Impact factor: 10.122

4.  Mouse and other rodent models of C to U RNA editing.

Authors:  Valerie Blanc; Nicholas O Davidson
Journal:  Methods Mol Biol       Date:  2011

5.  Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Kerstin Klaeser; Anthonin Reilhac; Georgios I Angelis; Steven R Meikle; Philip J Barter; Kerry-Anne Rye
Journal:  J Vis Exp       Date:  2017-05-02       Impact factor: 1.355

6.  Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice.

Authors:  Ngoc Nguyen; Veena Naik; Mei Y Speer
Journal:  Cardiovasc Pathol       Date:  2012-07-18       Impact factor: 2.185

7.  RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db.

Authors:  Abraham Neelankal John; Ramesh Ram; Fang-Xu Jiang
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

8.  In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.

Authors:  Blake J Cochran; William J Ryder; Arvind Parmar; Shudi Tang; Anthonin Reilhac; Andrew Arthur; Arnaud Charil; Hasar Hamze; Philip J Barter; Leonard Kritharides; Steven R Meikle; Marie-Claude Gregoire; Kerry-Anne Rye
Journal:  Diabetologia       Date:  2016-05-18       Impact factor: 10.122

9.  The influence of diabetes mellitus on periodontal tissues: a pilot study.

Authors:  Yoo-Jung Um; Ui-Won Jung; Chang-Sung Kim; Eun-Jung Bak; Jeong-Heon Cha; Yun-Jung Yoo; Seong-Ho Choi
Journal:  J Periodontal Implant Sci       Date:  2010-04-15       Impact factor: 2.614

10.  Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice.

Authors:  Sabrina Le Bouter; Marianne Rodriguez; Nolwen Guigal-Stephan; Sophie Courtade-Gaïani; Laura Xuereb; Catherine de Montrion; Vincent Croixmarie; Thierry Umbdenstock; Claire Boursier-Neyret; Michel Lonchampt; Manuel Brun; Catherine Dacquet; Alain Ktorza; Brian-Paul Lockhart; Jean-Pierre Galizzi
Journal:  PPAR Res       Date:  2010-10-10       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.